Single-source·Jul 17, 2026·2 sources analyzed
FTC reaches a Caremark settlement in its insulin-pricing case
The Federal Trade Commission says Caremark agreed to change pharmacy-benefit practices tied to insulin pricing, rebates, pharmacy access, and transparency, while the agency's broader PBM case remains pending for final order handling.
Image: Modern Action subject: Prescription drug prices
Connected public decisions
Follow the issue pages where this story connects to public action.
Contact officials
Act on Prescription drug prices
See the current decision, choose your position, and send a message through the issue page.
Take action on Prescription drug pricesSources used · 2 sources